Precision BioSciences, Inc.DTILNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank11
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P11
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-8.67%
2024-9.69%
2023-5.32%
20224.08%
202110.03%
202033.40%
201997.66%
201870.57%
201731.39%
20160.00%